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Evidence that CED-9/Bcl2 and CED-4/Apaf-1
localization is not consistent with the current model
for C. elegans apoptosis induction
E Pourkarimi
1, S Greiss
1,2 and A Gartner*
,1
In C. elegans, the BH3-only domain protein EGL-1, the Apaf-1 homolog CED-4 and the CED-3 caspase are required for apoptosis
induction, whereas the Bcl-2 homolog CED-9 prevents apoptosis. Mammalian B-cell lymphoma 2 (Bcl-2) inhibits apoptosis by
preventing the release of the Apaf-1 (apoptotic protease-activating factor 1) activator cytochrome c from mitochondria. In
contrast, C. elegans CED-9 is thought to inhibit CED-4 by sequestering it at the outer mitochondrial membrane by direct binding.
WeshowthatCED-9associateswiththeoutermitochondrialmembranewithindistinctfocithatdonotoverlapwithCED-4,which
is predominantly perinuclear and does not localize to mitochondria. CED-4 further accumulates in the perinuclear space in
response to proapoptotic stimuli such as ionizing radiation. This increased accumulation depends on EGL-1 and is abrogated in
ced-9 gain-of-function mutants. CED-4 accumulation is not sufﬁcient to trigger apoptosis execution, even though it may prime
cells for apoptosis. Our results suggest that the cell death protection conferred by CED-9 cannot be solely explained by a direct
interaction with CED-4.
Cell Death and Differentiation (2012) 19, 406–415; doi:10.1038/cdd.2011.104; published online 2 September 2011
Seminal studies on C. elegans apoptosis that occurs during
the invariant development of the worm are important for our
general understanding of the mechanism of apoptosis
induction. EGL-1, CED-4 and CED-3 are conserved proteins
required for the vast majority of the 131 cell deaths that occur
during nematode development.
1–3 The sole nematode B-cell
lymphoma 2 (Bcl-2) family member CED-9 (cell death
abnormal 9) is required to protect healthy cells from under-
goingapoptosis.
3Theced-9loss-of-functionmutantsundergo
inappropriate apoptosis in cells that are normally destined to
survive, whereas a ced-9 gain-of-function mutant is defective
forapoptosisinductionincellsnormallydestinedtodie.
3Inthe
worm, apoptosis generally involves the transcriptional upre-
gulationoftheBH3-onlydomainproteinegg-layingdefective1
(EGL-1), mediated by a combination of transcriptional
regulators acting on egl-1 in the speciﬁc cells destined to
die.
2,4 EGL-1 antagonizes CED-9 that, in turn, antagonizes
the proapoptotic activity of CED-4, the apoptotic protease-
activating factor 1 (Apaf-1) homolog.
2,4 In contrast to
mammalian systems where Apaf-1 activation is linked to the
release of cytochrome c from mitochondria,
5 in C. elegans the
decision between the survival or the death of a cell is reported
to be largely regulated by the direct interaction of CED-4 and
CED-9.
6 Mitochondrial CED-9 directly binds proapoptotic
CED-4 to inhibit apoptosis induction in cells destined
to survive. Upon transcriptional induction, EGL-1 binding to
CED-9 leads to a conformational change in CED-9, resulting
in the release of CED-4 and its translocation to the nuclear
periphery.
6ThiseventleadstoCED-4oligomerization andthe
induction of apoptosis through CED-3 caspase activation.
6–8
Recent structuralevidence suggeststhat the activatedCED-4
complex comprises a funnel-like octameric structure with
fourfold symmetry, each unit being deﬁned by an asymmetric
CED-4dimer.
9Thecavityofthisstructureprovidesspacefora
CED-3 dimer, and the induced proximity of these two CED-3
molecules is likely to be required for caspase activation.
9
The notion that EGL-1/CED-9 and CED-9/CED-4 can directly
interact is supported by yeast two-hybrid analysis, by
co-immunoprecipitation studies in heterologous systems
and by crystallographic evidence showing that CED-9 can
bind to a CED-4 dimer.
8–12 Previous cytological studies in
C. elegans embryos appeared to show the colocalization of
CED-9 and CED-4 on mitochondria in nonapoptotic cells, and
indicated that CED-4 translocation to the perinuclear space
was linked to apoptosis induction.
6 Although there is no
evidence for cytochrome c release in C. elegans, the release
of other mitochondrial factors such as AIF and EndoG as well
as mitochondrial fragmentation has been implicated in
apoptosis induction.
13,14 However, the apoptosis-defective
phenotypes associated with the depletion of these factors are
very weak and the importance of mitochondrial fragmentation
has been debated.
13,14 Furthermore, there is evidence that
CED-9 permeabilizes membranes in vitro and the over-
expression of CED-9 and Bcl-2 has been shown to lead
to mitochondrial fusion in mammalian tissue culture and in
C. elegans.
15–17 Here we revisit the localization of CED-9 and
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www.nature.com/cddCED-4. We conﬁrm that CED-9 is located at mitochondria and
show that it forms distinct foci. Unexpectedly, CED-4 does not
localizeatmitochondriainthegermlineandweprovidestrong
evidence that this is also the case during somatic develop-
ment. Using the C. elegans germ line as a model we show
that CED-4 perinuclear accumulation might prime cells for
apoptosis induction but is not sufﬁcient to induce apoptosis.
Results
We previously generated two speciﬁc CED-4 antibodies,
which we employed for immunostaining of dissected
C. elegans germ lines.
18 We conﬁrmed the perinuclear
staining pattern we observed with a third independently
generated CED-4 antibody, which speciﬁcally recognizes
CED-4 (Supplementary Figures 1a and b).
18 Using high-
resolution imaging, we found that CED-4 is expressed in the
entire germ line, located primarily around the nucleus with
additional much weaker granular structures occurring in the
cytoplasm (Figure 1a). As the current model of apoptosis
regulation depends on the direct interaction between CED-4
and mitochondrial CED-9, we next tried to establish whether
CED-4 staining was associated with mitochondria as
previously reported.
6 We visualized mitochondria by staining
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Figure 1 CED-4 is not localized on mitochondria in the germ line. (a) Representative pictures of late-stage pachytene germ cells were taken by Deltavision microscopy.
CED-4stainingwasdonewiththeCED-49104.1antibody.Mitochondriawerestainedwithanti-ATPsynthaseandanti-cytochromecantibodies.Thecorresponding3Dstacks
of the images are shown in Supplementary Movie 1 (CED-4) and Supplementary Movie 2 (CED-4/mitochondia); scale bar: 6mm. (b) CED-4 perinuclear accumulation upon
treatment with IR. A representative healthy cell, and corpses indicative of different stages of apoptosis progression are indicated in the right panel (1–6). A blow up of these
cellsisshowninFigure6a.NotethattheCED-4signalintensityin(b)isloweredby15%comparedwith (a)toallowforbettervisualization.(c)OMXmicroscopyofsinglegerm
cells before and after IR (CED-4 green, nuclear pore complex red). Scale bar: 4mm
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Cell Death and Differentiationdissected germ lines with a cocktail of monoclonal antibodies
recognizing conserved mitochondrial proteins. Speciﬁcity for
mitochondria was conﬁrmed by the perfect overlap of the
staining patterns of the different antibodies in germ lines
(Supplementary Figure 2a) as well as embryos (Supplemen-
taryFigure2b).Tooursurprise,wefoundthatCED-4doesnot
colocalize with mitochondria in germ cells (for late pachytene
cells see Figure 1a). The separate localization of CED-4 and
mitochondria is most apparent when scanning through
Z stacks of representative germ lines (Supplementary Movie
1, CED-4; Supplementary Movie 2, CED-4/mitochondria). We
found the same nonmitochondrial staining patterns for CED-4
in mitotic, transition zone, and both early- and late-stage
pachytene germ cells (data not shown). We conﬁrmed the
absence of CED-4 mitochondrial staining with an additional
CED-4 antibody we previously generated (Supplementary
Figure 1b). Finally, we transformed worms with a construct
encoding for CED-4::GFP driven by the ced-4 promoter. The
fusion protein was functional, rescuing the apoptosis defect of
the ced-4(n1162) loss-of-function allele (Figure 2a). When we
analyzed CED-4 localization in the transgenic worms using
immunoﬂuorescence with anti-GFP antibodies, we again did
not see any obvious colocalization of CED-4::GFP with
mitochondria (Figure 2b). The same predominantly peri-
nuclear CED-4 localization pattern was observed following
detection of the CED-4::GFP fusion protein by direct
ﬂuorescence, a ﬁnding that excludes the possibility that our
staining procedures led to a loss of mitochondrial CED-4
(Figure 2c). In summary, our data show that CED-4 does not
detectably localize to mitochondria in the germ line. Similarly,
labeling the endoplasmic reticulum (ER) did not reveal any
colocalization of the weak granular cytoplasmic CED-4 signal
with the ER (Supplementary Figure 3c). As previous studies
reporting a direct interaction of CED-9 and CED-4
at mitochondria were performed in embryos, we reasoned
that our results could be explained by the existence of a
fundamental difference between the regulation of develop-
mental apoptosis and germ cell apoptosis. We therefore
wished to reassess the cellular localization of CED-4 and
CED-9 during embryogenesis and larval development. Using
our panel of CED-4 antibodies we never saw CED-4 localized
at mitochondria. In contrast to our germ line stainings, we
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Figure 2 Perinuclear localization of CED-4::GFP. (a) The ced-4 gt1767 Ex[pced-4::ced-4::gfp::ced-4 3’UTR, unc-119(þ)] construct rescues the ced-4(n1162) apoptosis
defect. Only worms carrying the CED-4::GFP transgene were scored. (b) CED-4::GFP staining using anti-GFP antibodies. A white arrow indicates a very-late-stage corpse,
where mitochondria are fragmented, chromatin is condensed and CED-4 staining is absent (see Figures 1b and 6). (c) Direct visualizationof CED-4::GFP using ﬂuorescence
microscopy. The left panel shows DIC image of pachytene-stage germ cells and the right panel overlaps with ﬂuorescence image. Scale bar: 10mm
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Cell Death and Differentiationcould not conﬁrm the presence of CED-4 at nuclei with
absolute certainty, because of unspeciﬁc perinuclear staining
that was not present in germ lines (data not shown). We
therefore analyzed the same functional CED-4::GFP lines we
had used for assessing the localization of CED-4 in the germ
line. In agreement with our germ cell data, we found no
embryonic cells where CED-4::GFP staining colocalized with
mitochondria, and in all cells where CED-4 was detectable it
localized around the nucleus (Figure 3; Supplementary Movie
3, CED-4/mitochondria). We found the same perinuclear
CED-4::GFP localization by directly detecting CED-4 by GFP
ﬂuorescence in embryos, larvae and adult worms (data not
shown). Using antibodies kindly supplied by Barbara Conradt
(Supplementary Figure 3a), we could conﬁrm a partial overlap
between CED-9 and mitochondria (Figure 3; Supplementary
Movie 4, CED-9/mitochondria; Supplementary Movie 5,
CED-4/CED-9, Supplementary Figure 3b); however, we were
unable to detect any overlap between CED-4 and CED-9
(Figure 3, Supplementary Movie 5, CED-4/CED-9). Imaging
CED-9 in early-stage embryos using deconvolution micro-
scopy, we found that CED-9 staining was not evenly
distributed along mitochondria but appeared somewhat
punctate, often associated with but not perfectly overlapping
with mitochondria (Supplementary Figure 3b). A punctate
pattern was also observed in the germ line using the CED-9
antibody provided by the Conradt lab and the originally
described CED-9 antibody (data not shown).
6 To address
CED-9 localization more precisely, we employed structural
illumination opticam experimental microscopy(SI-OMX), a
technique that allows an approximately twofold higher
resolution compared with conventional deconvolution micro-
scopy.
19 Using OMX microscopy we observed a continuous
staining of the inner mitochondrial membrane with anti-ATP
synthase antibodies, whereas CED-9 staining appeared in
distinct dots (Figure 4a). Zooming in on individual mitochon-
drial branches revealed that the CED-9 dots tend to align next
to the mitochondrial inner membrane (Figure 4b, Supplemen-
tary Movie 6). This lack of overlap is consistent with OMX
microscopy resolving the bulk of mitochondrial cristae that
deﬁnetheinnermitochondrialmembrane,identiﬁedbymarker
proteins, from CED-9 associated with the outer mitochondrial
membrane. The localization of CED-9 foci next to the
mitochondrial surface became most obvious following a 3D
reconstruction of mitochondrial and CED-9 staining (Supple-
mentary Movie 7). The CED-9 staining pattern that we
observed is similar to the reported staining pattern of Bcl-2
in mammalian cells.
20,21 Unfortunately, because of technical
limitations it was not possible to triple stain nematode tissue
with CED-4, CED-9 and mitochondria-speciﬁc antibodies for
analysis using the OMX microscope. In summary, our results
suggest that there is no fundamental difference in CED-4
localization between hermaphrodite germ cells and somatic
cells, and that CED-4 localization does not overlap with
mitochondria and CED-9 in the vast majority of cell types
during somatic development and in the germ line. To
independently conﬁrm the localization of CED-4 and CED-9,
we developed procedures to achieve subcellular fractionation
(see Materials and Methods). Using this procedure, and
employing GAPDH as a cytosolic marker, a component of the
mitochondrial ATP synthase as a mitochondrial marker and
histone H2A as a nuclear marker, we conﬁrmed enrichment
of the respective compartments (Figure 4c). Staining with
CED-9 antibodies conﬁrmed enrichment in the membranous
fraction, whereas CED-4::GFP is enriched in the nuclear
fraction (Figure 4c). Analogous results were obtained in
independent experiments using CED-4 antibodies (data not
shown). In addition, we could not ﬁnd a direct interaction
between CED-4 and CED-9 in co-immunoprecipitation
experiments and upon mass spectroscopy of CED-4 pre-
cipitates (data not shown). Intriguingly, we found that CED-4
appears to colocalize with mitochondria and CED-9 in
secondary spermatocytes and spermatids, cell types where
apoptosis is not reported to occur
22 and where a role for
CED-4 and CED-9 cell death proteins is not known (Figure 5).
These cells make out only a tiny fraction of a total worm
extract. This CED-4 localization in spermatocytes and
spermatids was observed with two independent CED-4
antibodies and by staining for CED-4::GFP (data not shown).
In summary, our combined data suggest that CED-4 and
CED-9 do not localize in the vast majority of cells.
We next wished to determine whether changes in CED-4
subcellular localization occur during apoptosis progression.
For this, we focused our observations on the adult C. elegans
germ line, as apoptosis can be readily induced by ionizing
radiation in this tissue.
23 We and others have reported that
CED-4 accumulates at the nuclear periphery of germ cells
in response to ionizing radiation.
18,24 CED-4 accumulation
occurs within 6h of ionizing radiation and affects late
pachytene as well as mitotic germ cells and transition zone
nuclei (data not shown).
24,25 The IR-dependent perinuclear
accumulation of CED-4 appears strongest in late pachytene
cells, which are the only germ cells competent to die by
apoptosis (Figure 1b).
CED-4 perinuclear accumulation has previously been
associated with apoptosis induction in ced-9 (lf) embryos.
6
To test if CED-4 accumulation correlates with apoptosis, we
employed SIR-2.1 nuclear exclusion
18 as early-stage, mito-
chondrial fragmentation as mid-stage and chromosome
condensation as late-stage cytological markers for apoptosis
progression. Using high-resolution imaging, we found that IR-
dependentCED-4accumulationatthenuclearperipherydoes
not directly correlate with apoptosis. Indeed, comparing
individual cells that show IR-dependent CED-4 perinuclear
accumulation(markedintherightpanelofFigure1b)revealed
that some cells contained intact mitochondria, as well as
SIR-2.1 localized to the nucleus (cell numbered (1), Figures
1b and 6), whereas other cells were losing (2) or had lost
nuclear SIR-2.1 (3) and contained fragmented mitochondria
(3) and are thus corresponding to early- to mid-stage
apoptotic cells (Figures 1b and 6; CED-4; Supplementary
Movie 8 CED-4/mitochondria; Supplementary Movie 9,
CED-4/SIR-2.1). Thus, CED-4 perinuclear accumulation
occurs in both healthy and apoptotic cells. It should also be
noted that the dose of irradiation that we used only leads to a
twofold reduction in egg laying, implying that a high proportion
of germ cells can survive CED-4 perinuclear accumulation.
23
Only late-stage corpses (4) showed evidence of chromatin
fragmentation. These corpses also often showed excessive
CED-4 staining (CED-4 hyperaccumulation) at the nuclear
periphery and throughout the nucleus (4). In very-late-stage
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Figure 3 Staining of an embryo undergoing morphogenesis indicates that CED-4 does not colocalize with CED-9 and mitochondria. CED-4 is visualized using anti-GFP
antibodies (see Materials and Methods). The image shown is a projection of six Z stacks. The 3D scans are shown in Supplementary Movies 3–5. Scale bar: 10mm
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Cell Death and Differentiationcorpses (5 and 6), chromatin had started to condense and
CED-4 staining had disappeared (Figures 1b and 6; Supple-
mentary Movies 8 and 9). Thus, CED-4 hyperaccumulation
seems to be a consequence of corpse degradation and only
occurs in very few late-stage apoptotic cells. To more
precisely determine where CED-4 localizes before and after
ionizing radiation, we used OMX microscopy to observe CED-
4 and nuclear pore complexes by immunostaining, and found
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Figure 4 (a) Punctate CED-9 staining is associated with mitochondria. (b) A blow up of mitochondrial branches (indicated by arrows) is shown in the lower right panels.
Scale bar: 4mm. A 3D scan of the picture is shown in Supplementary Movie 6. (c) Subcellular fractionation.Mixed-stage C. elegansextracts were generated and fractionated
as described in Materials and Methods. Enrichment of subcellular compartments was conﬁrmed using antibodies against the indicated marker proteins
DAPI CED-4 CED-9 Mitochondria CED-4, CED-9 CED-4, Mitochondria
Figure 5 CED-4 and CED-9 staining overlaps in secondary spermatocytes. The CED-4 (10147.1) antibody was used
18
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Cell Death and Differentiationthat CED-4 is located outside of the nucleus before and after
irradiation (Figure 1c). Unfortunately, OMX microscopy does
not permit quantiﬁcation of the CED-4 perinuclear accumula-
tion in irradiated germ cells. We next wished to establish if the
core apoptosis pathway is needed for CED-4 perinuclear
accumulation. We analyzed an egl-1 loss-of-function mutant
as well as a ced-9 gain-of-function mutant, both of which have
dramatically reduced levels of DNA damage-induced germ
cell apoptosis. We found that CED-4 fails to accumulate at the
nuclear periphery in response to IR in an egl-1(lf) as well as in
a ced-9(gf) background (for representative pictures, see
Figure 7). In contrast to this, CED-4 strongly accumulates at
the nuclear periphery in ced-9(lf); ced-3(lf) double mutants,
where apoptosis induction is triggered by the loss of CED-9,
whereasapoptosis execution is blocked bythe absence of the
CED-3 caspase. Thus, we conﬁrm previous data obtained
Healthy cell Early corpse Mid corpse Late corpse Late corpse Very late corpse
Non-IR
12 34 5 6
CED-4
Dapi
Mitochondria
CED-4,
Mitochondria
SIR-2.1
IR
Figure 6 Various stages of germ cell apoptosis. Cells/corpses shown are indicated in Figure 1b. Scale bar: 6mm
0 Gy
120 Gy
N2 egl-1 ced-9 (gf) ced-9 (lf), ced-3
Figure 7 CED-4 perinuclear accumulation upon IR is absent in egl-1 loss-of-function and ced-9 gain-of-function mutants. The CED-4 (9104.1) antibody was used.
Scale bar: 10mm
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Cell Death and Differentiationfrom observing embryos suggesting that the loss of CED-9
leads to CED-4 perinuclear accumulation,
6 but our combined
data suggest that at least during germ cell apoptosis in wild-
type animals, this accumulation is not sufﬁcient for apoptosis
induction.
Discussion
In summary, we provide evidence that apoptosis regulation
mediated by CED-4 and CED-9 is unlikely to be solely
explained by a direct interaction between these two proteins.
Although we found colocalization of CED-4 and CED-9 at
mitochondria in spermatocytes and were thereby able to
conﬁrm that the reported in vitro interaction between CED-4
and CED-9 indeed appears possible in vivo, our data clearly
show that in the majority of tissues CED-4 and CED-9 do not
overlap. We cannot rule out the possibility that a small
undetectable fraction of CED-4 directly interacts with CED-9
in mitochondria. Alternatively, a small fraction of CED-9 might
be in the nucleus where it could colocalize with CED-4. We
think that the CED-9 background staining in the nuclear
fraction ofthe cell fractionation experiment is likely becauseof
imperfectfractionation,butwecannotruleoutthatsomeCED-
9 not detectable by cytology might be associated with the
nucleus. Nevertheless, we clearly show that the vast majority
of CED-4 is not associated with CED-9, a localization pattern
that according to the current model should result in active
CED-4 and initiation of apoptosis. It has been previously
reported that an antiapoptotic isoform of CED-4, CED-4L,
exists.
26 We were not able to differentiate between the
canonical CED-4 (CED-4S) and CED-4L in western blots,
likely because those two isoforms only differ by 22 amino
acids present in CED-4L and missing in CED-4S.
26 Given that
we used polyclonal antibodies that were raised against the
entire CED-4S protein, we think it is highly unlikely that our
stainingonlydetecttheantiapoptoticCED-4isoform.Ourdata
on CED-4 localization are largely based on the C. elegans
germ line system. Extruding germ lines generally allows for
more efﬁcient antibody penetration and staining when
compared with embryos, where staining procedures require
permeabilization of the egg shell. Nevertheless, the conver-
gence of the CED-4 localization pattern that we observed by
combinedcytologicalandbiochemicalmethods,aswellasthe
imaging of CED-4::GFP in the germ line and during
embryogenesis, indicates that the localization of CED-4 does
not fundamentally differ between the germ line and during
development.
Our notion that apoptosis induction might not be regulated
by the direct interaction between CED-4 and CED-9 is in
agreement with a recent report showing that a CED-9 mutant
defectiveinCED-4bindingisstillabletorescuetheembryonic
lethality associated with the excessive apoptosis in a ced-9
loss-of-function background.
27 As in mammals, C. elegans
apoptosis induction may require additional, as of yet unknown
factorsfortheactivationofCED-4.Inmammals,cytochromec
release from mitochondria is required for Apaf-1 activation.
However, the missing activator of CED-4 is unlikely to be
cytochrome c, as CED-4 lacks the WD40 domain needed
for cytochrome c binding. Furthermore, we did not observe
mitochondrialreleaseofcytochromecinresponsetoapoptotic
stimuli (data not shown). Analogous to mammalian systems,
the release of C. elegans AIF and EndoG from mitochondria,
as well as mitochondrial fragmentation, have been implicated
in C. elegans apoptosis induction. However, only a weak
apoptosis-defectivephenotypeisobservedfollowingdepletion
ofAIFandEndoG.
13,14Nevertheless,CED-9mighthavearole
in regulating the release of mitochondrial proteins. The Bcl-2
family of proteins is related to bacterial pore-forming proteins
andBcl-2hasbeenshowntobeable toform poresinsynthetic
membranes.
15,28–30 Furthermore, CED-9 is able to insert into
artiﬁcial membranes causing membrane permeabilization and
the fusion of membrane vesicles.
15 These ﬁndings are in line
with recent reports showing that CED-9 overexpression leads
totheexcessivefusionofmitochondrialmembranesinnotonly
mammalian tissue culture systems, but also in various
C. elegans tissues.
16,17 In summary, our results are not
consistent with the widely held notion that the decision
between C. elegans cell survival and cell death is mediated
by a direct interaction of the Apaf-1-like molecule CED-4 and
Bcl-2-like CED-9 in vivo. It will be interesting to explore how
CED-9 controls CED-4 activation in vivo and if this relates to
changes in mitochondrial permeability or dynamics.
Materials and Methods
C. elegans strains. C. elegans strains were maintained at 201C on NGM plates
and were fed with E. coli (OP50 strain) as described previously.
31 MT2547 ced-4
(n1162)III; MT7386 ced-9 (n2812)III, ced-3(n717)IV; MT4771 ced-9(n1950)
III; TG1768 egl-1(n3082)V; TG1765 ced-3(n717) IV; TG1766 ced-4(n1162)
unc-119(ed3)III; TG1767 gt1767 Ex[pced-4::ced-4::gfp::ced-4 3’UTR, unc-119
(þ)]ced-4(n1162) unc-119(ed3).
Antibodies. To generate the 9104.1 rabbit anti-CED-4 antiserum, 6  His-
tagged CED-4 (pGA333) was used for immunization, and MBP (maltose-binding
protein)-tagged CED-4 (pGA334) was used to purify the antibody as described by
Greiss et al.
18 The 9103.1 rabbit CED-4 antibody and the 10147.1 goat CED-4
antibody are described by Greiss et al.,
18 and anti-CED-9 antibodies are described
by Rolland et al.
17
Western blotting. Worms were lysed using a mini beadbeater (BioSpec
Products, Bartlesville, VA, USA) (3 20 s) set to maximum, using 0.7mm Zirconia
Beads (BioSpec Products) in 150ml of 7M urea lysis buffer containing 0.1M DTT,
0.05% Triton X-100, 25mM NaCl and 20mM HEPES/KOH, pH 7.5. The protein
lysate was incubated on ice for 30min followed by 20min of centrifugation at
13000r.p.m. in an Eppendorf tabletop centrifuge (Hamburg, Germany) at 41C.
Total protein concentration was measured by Bradford assay (Bio-Rad, Hercules,
CA, USA). Lysate equivalent to 10mg of protein was separated by SDS-PAGE
electrophoresis using 4–12% gradient gels (Invitrogen, Carlsbad, CA, USA).
Proteins were transferred to nitrocellulose membrane using the Invitrogen iBlot
system, followed by blocking with PBST (PBS supplemented with 0.1% Tween-20)
containing 5% milk powder for 30min at RT. Probing with anti-CED-9 antibody
(1:1000) was performed overnightat 41C. Washing was done three times at RT for
10min each with ice-cold washing buffer (PBS containing 0.1% Tween-20). HRP-
conjugateddonkeyanti-rabbitantibodies(JacksonImmunochemicals,WestGrove,
PA, USA) were used as secondary antibodies in a dilution of 1:10000. Incubation
was at RT.
Immunostaining and microscopy
Germ line staining for Deltavision microscopy. Immunostaining of germ
lines and imaging using Deltavision microscopy was done as described by Greiss
et al.,
18 using the following antibodies and dilutions: rabbit anti-CED-4 (9103.1)
1:100, rabbit anti-CED-4 (9104.1) 1:200, rabbit anti-CED-9 (CED-9.1) 1:150 and
goat anti-SIR-2.1 (126.1) 1:100. Antibodies used for mitochondrial staining are as
described by Greiss et al.,
18 using a 1:200 dilution, as follows: anti-ATP synthase
subunit-a (Mitosciences, Eugene, OR, USA; MS507), anti-cytochrome c (MSA06);
complex IV subunit 1 (MS404) and Pyruvate Dehydrogenase (MSP07) ATP
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Cell Death and Differentiationsynthase subunit-b (MS503). The ER was stained using anti-HDEL SC-53472
(Santa Cruz, Santa Cruz, CA, USA) (1:100). The following secondary antibodies
were used for detection (all from Molecular Probes, Eugene, OR, USA):
Alexa 488-labeled donkey anti-goat 1:200, Alexa 568-labeled donkey anti-rabbit
1:500, Alexa 647-labeled donkey anti-mouse 1:200, Alexa 488-labeled goat anti-
mouse IgG2a antibody 1:200, Alexa 568-labeled goat anti-mouse IgG1 antibody
1:200 and Alexa 647-labeled goat anti-mouse IgG2b antibody 1:200.
Embryo. Sample preparation was done on poly-lysine (0.1% w/v, Sigma,
St. Louis, MO, USA)-coated superfrost Plus slides (VWR International, West
Chester, PA, USA) and ﬁxation was done as described for the germ line with the
following modiﬁcations:
18 post ﬁxation was done at RT. Pre-blocking with Image IT
FX signal enhancer (Invitrogen) was done for 15min. For the staining shown in
Figure 2, the CED-4::GFP fusion was detected by the ‘GFP booster, Chromotex’
anti-GFPmonovalentantibodythatisdirectlycoupledtoATTO488ﬂuorescentdye,
and which was incubated (1:200) with the secondary antibodies in this straining.
Antibodies were used at the same dilution as for the germ line staining.
Staining for SI-OMX microscope. Embryos were prepared and ﬁxed as
described above
18 except for the permeabilization, which was done by four
10-min incubations at RT, and preblocking with Image IT FX signal enhancer
(Invitrogen),whichwas donefor 10minat RT. Primaryantibodiesandtheir dilutions
were as follows: IgG2b anti-ATP synthase subunit-a (MS507) 1:150, IgG2a anti-
cytochromec (MSA06) 1:150 and CED-9.1antibody1:100. Secondaryantibodies
were as follows: Alexa 568-labeled donkey anti-rabbit (Molecular Probes) 1:400,
Alexa 488-labeled goat anti-mouse IgG2a antibody (Molecular Probes) 1:150,
Alexa 488-labeled goat anti-mouse IgG2b antibody (Molecular Probes) 1:150 and
DyLight 549 labeled Goat anti-mouse IgG2b (Jackson Immunochemicals) 1:100.
Germ lines were ﬁxed and stained as described above, except that germ lines were
ruptured before ﬁxation. Mouse monoclonal antibody MAb414 (1:150, Covance
Research Products, Princeton, NJ, USA) was used to stain the nuclear pore
complex.
Image analysis and 3D reconstruction. Images were analyzed using
softWoRx Suite and softWoRx Explorer software (AppliedPrecision, Issaquah, WA,
USA). SI-OMX 3D reconstructions and subtraction of noise were performed using
Imaris software (Bitplan AG, Scientiﬁc Software, Zurich, Switzerland).
Generation of transgenic worms. The sequence of the ced-4::gfp fusion
plasmid(pGA402)containingced-4promoter,ced-4genomicsequencefollowedby
GFP inserted right before the stop codon and the ced-4 30-UTR can be obtained
upon request. The ced-4 promoter and ced-4 genomic sequences were ampliﬁed
using the following primers:
GA2194: [50-TGCAGGCGCGCCCATGCTTTCGTGGTGACATTG-30] and
GA2199: [50-AAAGCGGCCGCCACAGCATGCAAAATTTTTGAG-30].
To clone the 30-UTR,
GA2223a: [50-TCGAGGCCGGCCTAAAACCTATCGTGTACAATATTG-30] and
GA2224:[50-TCGAGGGCCCGTTCTTGCATTCGATCTTCTCAATTTG-30]we reuse d.
To create transgenic lines, 5mg of pGA402 plasmid was used to transform TG1766
ced-4(n1162); unc-119(ed3) worms by biolistic bombardment using a
PDS-100/He particle delivery system (Bio-Rad).
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Subcellular fractionation
Lysis of worms and release of cytoplasmic content. Worm pellet (200ml;
mixed stage) was used. Worms were washed 3  in M9 buffer and collected by
sedimentation. Worms were resuspended in 0.2ml ice-cold extraction buffer CE1
supplemented with protease inhibitor (Qiagen Qproteome Cell Compartment Kit,
Qiagen, Hamburg, Germany). To disrupt the cuticles and to release the cells and
cytoplasmic content, 100–150ml 0.7mm Zirconia Beads (BioSpec Products) were
added to the vial, followed by bead beating (Mini-Beadbeater-8, BioSpec Products)
at max speed for three times each 5s. Approximately 70% lysis was conﬁrmed by
microscopic observation, scoringforreleased nuclei.Toavoiddisruptingsubcellular
compartments, worms were not frozen before lysis. To further lyse the sample and
toclearthelysatefromnon-lysedwormsandwormcuticles,thesamplewaspassed
through cell-lysate homogenizer tubes (Qiashredder, Qiagen) and centrifuged for
2min at 100 r.c.f. (Eppendorf cooling benchtop centrifuge). The lysate was then
transferred to new homogenizer tubes and spun for 30s at 100 r.c.f. and the
procedure was repeated once more. After a ﬁnal spin for 10s, the lysate was free
from non-lysed worms and their cuticles. Subsequently, subcellular fractionation
was performed according to the manufacturer’s instructions, but using only 20% of
the recommended volumes. After fractionation, the samples were incubated with 4
times their volume of acetone at  201C for 3h, followed by centrifugation at
13200r.p.m.for30minat41C.Thesupernatantwasremovedandthepelletwasair
dried. The pellet was resuspended in 100ml of 2% SDS and heated at 651C for
30min with occasional vortexing. Protein concentration of all the fractions was
measured using the Pierce BCA protein concentration assay (Rockford, IL, USA)
following the manufacturer’s instructions. For western blotting, 5mg of each sample
was used. The antibodies used were: anti-histone H2A antibody (Abcam,
Cambridge, UK; AB13923) 1:1000; anti-ATP synthase subunit-a antibody
(Mitosciences) 1:2500; anti-GAPDH antibody (Sigma; G8795) 1:10000; anti-
GFP antibody (Cell Signaling Technology, Beverly, MA, USA; 2956) 1:1000 and
anti-CED-9 antibody 1:2000.
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